Add this topic to your myFT Digest for news straight to your inbox
Chief executive of aspirin-to-Roundup group has limited options to sort fallout of ill-fated Monsanto purchase
Bill Anderson quashes speculation after suspending break-up of indebted German drugs-to-pesticides group
Bill Anderson expects further profit declines at the aspirin-to-agriculture conglomerate in 2024
Bill Anderson says group is generating a series of promising new drugs after R&D strategy change
Halted trial of prospective blockbuster treatment follows latest US legal blow over weedkiller Roundup
German group is examining spinning off its crop sciences or consumer health businesses in effort to restore fortunes
International Edition